Holen Sie sich die Stockscreener-App
1.52
0.00%
0.00
Handel nachbörslich:
1.47
-0.05
-3.29%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FBIO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.52
Offen:
$1.5
24-Stunden-Volumen:
281.88K
Relative Volume:
0.75
Marktkapitalisierung:
$41.96M
Einnahmen:
$80.97M
Nettoeinkommen (Verlust:
$-78.31M
KGV:
-0.1371
EPS:
-11.0849
Netto-Cashflow:
$-129.56M
1W Leistung:
-5.59%
1M Leistung:
-0.65%
6M Leistung:
-6.75%
1J Leistung:
-18.72%
1-Tages-Spanne:
$1.44
$1.55
1-Wochen-Bereich:
$1.44
$1.63
52-Wochen-Spanne:
$1.355
$2.89
Fortress Biotech Inc Stock (FBIO) Company Profile
Firmenname
Fortress Biotech Inc
Sektor
Branche
Telefon
781-652-4500
Adresse
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Vergleichen Sie FBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
1.52 | 41.96M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-15 | Fortgesetzt | ROTH MKM | Buy |
| 2022-08-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-10-02 | Eingeleitet | The Benchmark Company | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2018-02-28 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | Eingeleitet | Rodman & Renshaw | Buy |
| 2017-03-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-10-03 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten
SEC Form POS AM filed by Fortress Biotech Inc. - Quantisnow
Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Fortress Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire
Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan
Fortress Biotech, Inc. (NASDAQ:FBIO) Q4 2024 Earnings Call Transcript - Insider Monkey
Fortress Biotech’s Mixed Earnings Call: Emrosi’s Launch and Challenges - TipRanks
Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan
MUSTANG BIO, INC. SEC 10-K Report - TradingView
Journey Medical Reports 2024 Financial Results - TipRanks
FDA Green Light for Journey Medical's Rosacea Drug Reshapes 2024 Performance - StockTitan
Fortress Biotech Inc (FBIO) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus
Fortress Biotech (NASDAQ:FBIOP) Trading Up 3.9% – Here’s Why - Defense World
Fortress Biotech (FBIO) Expected to Announce Earnings on Thursday - Defense World
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 - GlobeNewswire
Journey Medical Sets Date for 2024 Annual Results: Dermatology Leader's Financial Update - Stock Titan
Atria Investments Inc Buys 16,841 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Partex And Fortress Biotech Announce Collaboration To Accelerate Biopharma Asset Evaluation - Nasdaq
Fortress Biotech, Partex Team Up for Asset Identification, Evaluation Using AI -March 17, 2025 at 09:36 am EDT - Marketscreener.com
Fortress Biotech partners with Partex for AI-driven drug discovery By Investing.com - Investing.com Australia
Fortress Biotech partners with Partex for AI-driven drug discovery - Investing.com
Partex NV and Fortress Biotech, Inc. Announce Strategic Collaboration to Leverage AI in Biopharmaceutical Drug Discovery - Nasdaq
Partex and Fortress Biotech Announce Strategic - GlobeNewswire
AI Breakthrough: Fortress Biotech's New Partnership Transforms Drug Development Process - StockTitan
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
Equities Analysts Offer Predictions for FBIO Q1 Earnings - Defense World
Fortress Biotech (NASDAQ:FBIO) Receives “Buy” Rating from Roth Mkm - Defense World
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference - GlobeNewswire
Benign Growth For Fortress Biotech, Inc. (NASDAQ:FBIO) Underpins Its Share Price - Simply Wall St
CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma - Longview News-Journal
Lake Street Downgrades Checkpoint Therapeutics to Hold From Buy, $4.10 Price Target - Marketscreener.com
Checkpoint (CKPT) Shares Skyrocket After A Takeover Agreement - Stocks Telegraph
Checkpoint Therapeutics Shares Leap Premarket on Takeover by Sun Pharma -March 10, 2025 at 06:24 am EDT - Marketscreener.com
Sun Pharma Pays 66% Premium in $355M Checkpoint Therapeutics Acquisition - Stock Titan
Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical -March 10, 2025 at 04:50 am EDT - Marketscreener.com
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher - Mint
India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million - Reuters
Sun Pharma to acquire US based onco-derma firm Checkpoint for $355 mn - Business Standard
Sun Pharma to acquire 100% stake in Nasdaq-listed Checkpoint Therapeutics - Business Standard
India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million -March 09, 2025 at 11:49 pm EDT - Marketscreener.com
Sun Pharma to Acquire Checkpoint Therapeutics - Quantisnow
India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln By Investing.com - Investing.com Australia
India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln - Investing.com
Sun Pharma to acquire Checkpoint Therapeutics for Rs 3,000 crore - Business Upturn
Mustang Bio meets Nasdaq’s equity listing requirements By Investing.com - Investing.com South Africa
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - The Manila Times
Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Down 78.3% in February - Defense World
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewswire
Trading (FBIOP) With Integrated Risk Controls - news.stocktradersdaily.com
FDA extends review of Fortress Biotech's CUTX-101 drug - MSN
Is Fortress Biotech Inc (NASDAQ: FBIO) Still Hot This Week? - Stocks Register
Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):